Japan Intellectual Property Rights: ENGINEERED CELLS, T CELL IMMUNE MODULATING ANTIBODIES, AND METHODS FOR USING THE SAME

Japan, Oct. 15 -- DANA FARBER CANCER INSTITUTE INC has got intellectual property rights for 'ENGINEERED CELLS, T CELL IMMUNE MODULATING ANTIBODIES, AND METHODS FOR USING THE SAME.' Other related details are as follows:

Application Number: JP,2024-018466

Category (FI): A61K31/7088,A61K35/17,A61K39/395@D,A61K39/395@N,A61K39/395@T,A61K40/11,A61K40/15,A61K40/31,A61K40/33,A61K40/42,A61K47/68,A61K48/00,A61P35/00,C12N1/15,C12N1/19,C12N1/21,C12N15/62@Z,C12N15/63@Z,C12N5/0783,C12N5/10,C12Q1/02

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Feb. 9, 2024

Publication Date: April 16, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.